SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories informs about newspaper publication

18 Jan 2025 Evaluate
Pursuant to Regulations 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Morepen Laboratories has enclosed newspaper advertisements published on 18th January 2025 in the Financial Express (English) & Jansatta (Hindi), completion of dispatch of the notice of Extra-Ordinary General Meeting ('meeting') including details of e-Voting and meeting to be held through electronic mode (‘VC/OAVM’). The aforesaid advertisements are being made available at the website of the company at www.morepen.com.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

41.33 0.20 (0.49%)
17-Apr-2026 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.00
Dr. Reddys Lab 1227.00
Cipla 1238.90
Zydus Lifesciences 943.65
Lupin 2310.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×